Related Experiment Video
Updated: Jan 23, 2026
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects
Anne K Mühlig1, Jun Young Lee2, Markus J Kemper3
1Department of Pediatrics, University Hamburg-Eppendorf, 20246 Hamburg, Germany. a.dettmar@uke.de.
Insights
Levamisole is an effective and safe treatment for children with frequently relapsing or steroid-dependent nephrotic syndrome, reducing relapse rates and minimizing steroid toxicity. This therapy offers a less toxic and more affordable option for managing this common pediatric kidney disease.
Area of Science:
- Pediatric Nephrology
- Immunology
Background:
- Steroid-sensitive nephrotic syndrome (SSNS) is a common pediatric kidney disease.
- Many children experience relapsing or steroid-dependent disease, leading to significant steroid toxicity from repeated treatments.
- Alternative therapies are needed to manage frequent relapses and steroid dependency.
Purpose of the Study:
- To review recent data on the efficacy of levamisole in pediatric patients with frequently relapsing or steroid-dependent nephrotic syndrome.
- To assess levamisole's role in reducing relapse rates and mitigating treatment toxicity.
Main Methods:
- Review of recent randomized controlled trials (RCTs) and observational studies.
- Assessment of levamisole's efficacy and safety profile in managing SSNS.
Main Results:
- Levamisole has demonstrated effectiveness in reducing the relapse risk in SSNS.
- Studies indicate a low frequency of side effects associated with levamisole therapy.
- Levamisole is considered a less toxic and more cost-effective treatment option.
Conclusions:
- Levamisole is a viable and beneficial therapeutic option for pediatric patients with frequently relapsing or steroid-dependent nephrotic syndrome.
- Its use can help decrease relapse rates and reduce the cumulative toxicity of steroid therapy.
- Levamisole offers an accessible and safe alternative for managing this condition.
Abstract:
Steroid sensitive nephrotic syndrome is one of the most common pediatric glomerular diseases. Unfortunately, it follows a relapsing and remitting course in the majority of cases, with 50% of all cases relapsing once or even more often. Most children with idiopathic nephrotic syndrome respond initially to steroid therapy, nevertheless repeated courses for patients with relapses induce significant steroid toxicity. Patients with frequent relapses or steroid dependency thus require alternative treatment, such as cyclophosphamide, cyclosporine, tacrolimus, mycophenolate mofetil, levamisole, or rituximab. To reduce the relapse rate, several drugs have been used. Among these, levamisole has been considered the least toxic and least expensive therapy. Several randomized controlled trials (RCT) showed that levamisole is effective in reducing the relapse risk in steroid sensitive forms of nephrotic syndrome with a low frequency of side effects. Levamisole is a synthetic imidazothiazole derivative with immune-modulatory properties. In this article, we review recent data from randomized trials and observational studies to assess the efficacy of levamisole in frequently relapsing nephrotic syndrome and steroid-dependent nephrotic syndrome.
More Related Videos
Related Concept Videos
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:24Nephrotic Syndrome I : Introduction
01:26Nephrotic Syndrome II : Assessment and Medical Management
01:24Nephrotic Syndrome III : Nursing Management
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: